Reasearch Awards nomination

Email updates

Keep up to date with the latest news and content from Clinical and Translational Allergy and BioMed Central.

Open Access Highly Accessed Research

Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients

Wendy SJ Malskat12, André C Knulst1, Carla AFM Bruijnzeel-Koomen1 and Heike Röckmann1*

Author Affiliations

1 Department of Dermatology/Allergology, University Medical Centre Utrecht, Heidelberglaan 100, G 02.124, Utrecht 3584 CX, The Netherlands

2 Current Address: Department of Dermatology, Erasmus Medical Centre, Rotterdam, The Netherlands

For all author emails, please log on.

Clinical and Translational Allergy 2013, 3:20  doi:10.1186/2045-7022-3-20

Published: 24 June 2013

Abstract

Background

Non-steroidal anti-inflammatory drugs (NSAIDs) frequently cause adverse drug reactions. Many studies have shown that drugs which selectively inhibit the cyclooxygenase-2 enzyme (COX-2) are safe alternatives in the majority of patients. However, hypersensitivity reactions to COX-2 inhibitors have been published. Hardly any data are available regarding the safety of alternatives in case of COX-2 inhibitor hypersensitivity. We aimed to investigate the tolerance to COX-2 inhibitors in patients with non-selective NSAID hypersensitivity. Furthermore, in COX-2 hypersensitive patients tolerance of a second COX-2 inhibitor was investigated.

Methods

We retrospectively analyzed 91 patients with proven non-selective NSAID hypersensitivity that underwent oral challenges with a COX-2 inhibitor. Patients with intolerance to the first challenged COX-2 inhibitor received a second challenge with a different COX-2 inhibitor.

Results

19 out of 91 (21%) patients had a positive reaction to the first oral challenge with a COX-2 inhibitor. 14 of them underwent a second challenge with a different COX-2 inhibitor and 12 (86%) did not react.

Conclusions

A relatively high percentage (21%) of the non-selective NSAID hypersensitive patients did not tolerate a COX-2 inhibitor and oral challenge is advised prior to prescription of a COX-2 inhibitor. For the majority of patients reacting to a COX-2 inhibitor an alternative can be found.

Keywords:
COX-2; Drug hypersensitivity; Nonsteroidal anti-inflammatory drugs; Oral provocation